Published July 31, 2019 | Version v1
Journal article Open

Changes in human peripheral blood mononuclear cell (HPBMC) populations and T-cell subsets associated with arsenic and polycyclic aromatic hydrocarbon exposures in a Bangladesh cohort

Description

Exposures to environmental arsenic (As) and polycyclic aromatic hydrocarbons (PAH) have been shown to independently cause dysregulation of immune function. Little data exists on the associations between combined exposures to As and PAH with immunotoxicity in humans. In this work we examined associations between As and PAH exposures with lymphoid cell populations in human peripheral blood mononuclear cells (PBMC), as well as alterations in differentiation and activation of B and T cells. Two hundred men, participating in the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh, were selected for the present study based on their exposure to As from drinking water and their cigarette smoking status. Blood and urine samples were collected from study participants. We utilized multiparameter flow cytometry in PBMC to identify immune cells (B, T, monocytes, NK) as well as the T-helper (Th) cell subsets (Th1, Th2, Th17, and Tregs) following ex vivo activation. We did not find evidence of interactions between As and PAH exposures. However, individual exposures (As or PAH) were associated with changes to immune cell populations, including Th cell subsets. Arsenic exposure was associated with an increase in the percentage of Th cells, and dose dependent changes in monocytes, NKT cells and a monocyte subset. Within the Th cell subset we found that Arsenic exposure was also associated with a significant increase in the percentage of circulating proinflammatory Th17 cells. PAH exposure was associated with changes in T cells, monocytes and T memory (Tmem) cells and with changes in Th, Th1, Th2 and Th17 subsets all of which were non-monotonic (dose dependent). Alterations of immune cell populations caused by environmental exposures to As and PAH may result in adverse health outcomes, such as changes in systemic inflammation, immune suppression, or autoimmunity.

Data availability

The data set for this study can be accessed via the following DOI: 10.6084/m9.figshare.8144492 (doi.org/10.6084/m9.figshare.8144492).

Files

journal.pone.0220451.pdf

Files (2.2 MB)

Name Size Download all
Article
md5:5c238601f02491421000e74e87f6c8a8
1.2 MB Preview Download
md5:44cbee0714a93ebe4f7e1d3267b48993
590.5 kB Preview Download
md5:943d567fc346579f979fc454b4bac291
374.3 kB Preview Download

Additional details

Identifiers

DOI
10.1371/journal.pone.0220451
Other
oai:uchicago.tind.io:6285

Funding

National Institute of Environmental Health Sciences
ViCTER Program
National Institute of Environmental Health Sciences
Superfund Basic Research Program
National Institute of Environmental Health Sciences
P30 ES009089

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Human Genetics, Medicine, Public Health Sciences